
| High dosage of methylprednisolone as a rescue, second-line treatment in COVID-19 patients who failed to respond to tocilizumab #MMPMID32816701Conticini E; Franchi F; Bennett D; Valente S; Mazzei MA; Bargagli E; Volterrani L; Scolletta S; Frediani BAnn Rheum Dis 2022[Oct]; 81 (10): e202 PMID32816701show ga
?|*COVID-19 Drug Treatment[MESH]|*Methylprednisolone/therapeutic use[MESH]|Antibodies, Monoclonal, Humanized/therapeutic use[MESH]
  
DeepDyve Pubget Overpricing | 
|